【美股财报】Prime Medicine Inc 2024年度报告.pdf

Blueprint Medicines Corp 2024年度报告

How Off-Label Use of Medicines Drives Health-Care Use and Disability

Annex 1 Socio-Economic Analysis Of the potential restriction of the perand polyfluoroalkyl substances (PFAS) used in the production, packaging and delivery of human medicinal products

Report of the second joint meeting (hybrid) of the WHO Global Advisory Committee on Vaccine Safety and the WHO Advisory Committee on Safety of Medicinal Products, 14–16 December2022

Praxis Precision Medicines Inc 2025年季度报告

Position on the Use of Artificial Intelligence in the Medicinal Product Lifecycle

Medicine shortages: EFPIA proposal for action

Disc Medicine Inc 2024年度报告

Editas Medicine Inc 2025年季度报告

Disc Medicine Inc美股招股说明书(2025-01-21版)